Immunovant, Inc. (IMVT) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to Roy Van's first quarter 2026 earnings conference call. At this time, all participants are in the listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask questions during the session, you need to press star 1 and 1 on your telephone. Please be advised that today's call is being recorded. I would now like to hand the conference over to your first speaker today. Definitely. Thank you. Please go ahead. Good morning, and thanks for joining today's call to review Roygan's financial results for the first quarter ended June 30th, 2026. I'm Stephanie Lee with Roygan. Presenting today, we have Mac Lyons, CEO of Roygan. For those chiming in via conference call, you can find the slides being presented today, as well as the press release announcing these updates on our IR website at www.investor.roygan.com. We'll also be providing the current slide numbers as we present to help you follow along. I'd like to remind you that we'll be making certain forward-looking statements during today's presentation. We strongly encourage you to review the information that we have filed with the FCC for more information regarding these forward-looking statements and related risks and uncertainties. And with that, I'll turn it over to Matt. Thank you, Steph, and good morning, everybody, and thank you for joining. This is a little bit of a come-before-the-storm moment for us, and so a pretty quiet quarter, and maybe not the most interesting of our earnings calls in recent memory, but nonetheless a lot of great progress in the business, and certainly we're expecting a gem-packed second half, as I'll get to in a moment. So I'll be relatively brief in my remarks, and then we'll go to Q&A. I'm going to s...